Pangenomic Health Inc.
NARA
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -286.90K | -279.10K | -603.90K | -144.90K | -1.86M |
| Total Depreciation and Amortization | 100.00 | 100.00 | 100.00 | 1.50K | 2.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.80K | 87.60K | 70.20K | 23.50K | 1.70M |
| Change in Net Operating Assets | 169.80K | 161.40K | 512.40K | 131.10K | 112.10K |
| Cash from Operations | -115.20K | -30.10K | -21.20K | 11.30K | -43.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 187.50K | -- | 0.00 | 0.00 | 47.00K |
| Total Debt Repaid | -62.50K | -- | -- | -- | -- |
| Issuance of Common Stock | 88.60K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.30K | 44.30K | 1.70K | 0.00 | -1.70K |
| Cash from Financing | 118.00K | 30.90K | 1.20K | 0.00 | 33.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.80K | 800.00 | -20.00K | 11.30K | -10.40K |